Managing diabetes requires precision and the right tools. The latest collaboration between Dexcom G7 and Tandem t:slim X2™ insulin pump with Control-IQ Technology brings a powerful combination that could revolutionize your diabetes care. In this blog post, we'll explore the advantages of this integration and how it can elevate your diabetes management.
The Synergy of Dexcom G7 and Tandem t:slim X2 Integration
DexCom Inc., a global leader in continuous glucose monitoring (CGM), recently announced the compatibility of the Dexcom G7 CGM System with the Tandem t:slim X2 insulin pump in Europe and South Africa, following the successful launch in the United States. The synergy between these two cutting-edge technologies aims to provide a seamless and effective solution for individuals managing diabetes.
What is Automated Insulin Delivery (AID)?
Automated Insulin Delivery (AID) is a game-changer in diabetes management. It involves the integration of a continuous glucose monitor (CGM) with an insulin pump. The Dexcom G7 and Tandem t:slim X2 combination utilizes the glucose values and trends from the CGM system to make automatic adjustments to insulin delivery, helping users achieve increased time in range and reducing the day-to-day burden of managing diabetes.
Benefits of Dexcom CGM and AID Systems Integration
The integration of Dexcom CGM and Tandem t:slim X2™ insulin pump offers unparalleled benefits:
More Time in Range: Dexcom users with Type 1 Diabetes (T1D) have experienced 11% more time in range, translating to over 2.6 hours a day.
Fewer Highs and Lows: Users report fewer instances of high and low glucose levels, contributing to a more stable daily experience.
In-the-Moment Treatment Decisions: Make informed treatment decisions without the need for constant fingersticks, providing flexibility and control.
Long-Term Benefits of AID Systems
A 2022 educational guide by the Association of Diabetes Care & Education Specialists highlights the long-term advantages of AID systems:
Fewer Severe Episodes: AID systems reduce the frequency and severity of hypoglycemia and hyperglycemia.
Reduced Diabetes Distress: Individuals experience less worry and stress related to diabetes management.
Increased Confidence: More time in the target range boosts confidence in diabetes care.
Real-World Results and Clinical Validation
Results from a seven-year real-world CGM study, showcase significant reductions in HbA1c and a lower risk of diabetic retinopathy progression when using Dexcom CGM. The study further emphasizes the benefits when connected to the Tandem t:slim X2 insulin pump.
Fastest CGM Connection with Tandem t:slim X2
The Dexcom G7 boasts a 30-minute sensor warm-up time, making it the fastest CGM connected to the Tandem t:slim X2 insulin pump. This efficiency ensures users spend more time benefiting from their AID system.